<DOC>
	<DOCNO>NCT00402571</DOCNO>
	<brief_summary>The study objective determine whether liver injury develop alcoholic patient ingest therapeutic dos APAP three consecutive day . Volunteers recruit two community detoxification center take either acetaminophen ( 4 g/day ) placebo 3 consecutive day remain facility additional 2 day monitoring . The primary measure aminotransferase measure take baseline Days 2-5 . We hypothesize would difference aminotransferase measure acetaminophen placebo study group .</brief_summary>
	<brief_title>Hepatic Function During Following Three Days Acetaminophen Dosing Alcoholics</brief_title>
	<detailed_description />
	<mesh_term>Alcohol-Related Disorders</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Inclusion Criteria Any patient , regardless gender ethnicity , : 1 . 18 year old 2. admit one two control access alcohol detoxification center positive BAL time admittance 3. sign write informed consent form . Patients exclude study baseline follow present : 1. serum acetaminophen level great 20 mcg/ml 2. serum AST ALT level great 200 IU/L 3 . INR great 1.5 4. female , positive betasubunit chorionic gonadotropin 5. clinically intoxicate , psychiatrically impaired unable give inform consent 6. know hypersensitivity acetaminophen 7. history ingest four gram APAP per day four day precede study enrollment 8. currently enrol another trial enrol another trial precede three month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>acetaminophen</keyword>
	<keyword>alcohol</keyword>
	<keyword>liver injury</keyword>
</DOC>